Skip to main content
. Author manuscript; available in PMC: 2011 Aug 1.
Published in final edited form as: J Pediatr Gastroenterol Nutr. 2010 Aug;51(2):191–197. doi: 10.1097/MPG.0b013e3181d32756

TABLE 2. Demographic Characteristics by Response to Therapy (STUDY 2).

Covariate (frequency or median, range) SVR n = 32 (55%) No SVR n = 26 (45%) P value

Gender (Male) (n=17) 53% (n=15) 58% 0.72

Age (yr) 12.8 (7.2 –18.3) 13.0 (5.9 – 19.2) 0.94

Infection Duration (yr) 12.3 (0.6 – 18) 10.7 (2.8 – 19.2) 0.86

Genotypes 1 (n=20) 63% 1 (n=25) 96% 0.004
2 (n=6) 2 (n=1)
3 (n=5)
4 (n=1)

Overweight (BMI >85%ile) (n=6) 19% (n=11) 42% 0.05

Testing frequency of genotype 1. SVR, sustained virologic response;